MedMen Enterprises Inc.
MMNFF · OTC
3/25/2023 | 12/24/2022 | 9/24/2022 | 6/25/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.02 | 0.01 | -0.00 |
| FCF Yield | -60.22% | -20.08% | -18.19% | -6.40% |
| EV / EBITDA | -56.63 | 375.16 | -222.09 | -4.75 |
| Quality | ||||
| ROIC | -16.52% | -3.22% | -6.47% | -6.97% |
| Gross Margin | 48.29% | 50.93% | 49.45% | 51.80% |
| Cash Conversion Ratio | 0.48 | -0.07 | 0.47 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.31% | -3.54% | -3.46% | -2.96% |
| Free Cash Flow Growth | -176.31% | 51.16% | -115.34% | 59.93% |
| Safety | ||||
| Net Debt / EBITDA | -53.52 | 351.94 | -192.85 | -4.02 |
| Interest Coverage | -0.88 | -0.22 | -0.50 | -2.17 |
| Efficiency | ||||
| Inventory Turnover | 0.96 | 1.06 | 1.67 | 1.60 |
| Cash Conversion Cycle | -17.38 | 14.35 | -8.47 | -48.48 |